Incrementally, The Case Is Strengthening For a Year-End Rally. Fears Easing of Dual Issues of “Supply-Chain Glitches” + Vaccines= Shifting Away From “Ping Pong”

FDA advisers endorse Moderna booster

Yesterday, the FDA outside panel of advisers endorsed Moderna’s request for a booster shot. This was largely expected but still an incremental positive. After all, there was a modicum of risk, and more importantly, the combination of booster vaccines and COVID-19 therapeutics (Merck pill) are important steps in eventually pushing COVID-19 towards “endemic” status. And this allows the US economy, policymakers, and private enterprises to push towards a path of normalization.

The video in this report is only accessible to members

Supply chain glitches are easing = beginning of the end

One of the my favorite headlines this week is the statement from Jamie Dimon, CEO of JPMorgan, he predicts the supply chain disruptions will be eased into 2022. It is a common sense statement, but an important perspective. Many investors fret about the near-term impact on margins, delivery times, visibility, etc. due to the glitches in the supply chain. There are multiple factors driving this, including:

  • production delays overseas and in the US
  • backups at the ports of entry (ships offshore)
  • lack of supply of drivers and workers to move goods from the ports
  • marginal labor shortages everywhere
This is cre...

Unlock this article with a FREE 30-Day Trial!

An FSI Pro, or FSI Macro subscription is required in order to access this content.

*Free trial available only on a monthly plan

More from the author

Disclosures (show)

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

🎁 Unlock 1 extra article by joining our Community!

You’ve reached your limit of 2 free monthly articles. Please enter your email to unlock 1 more articles.

Already have an account? Sign In

Don't Miss Out
First Month Free